When TIM-3 binds to their ligand galactin-9 (Gal-9), it acts as a downregulator of anti-tumor immunity by inducing Th1 apoptosis and tolerance of T cells (Fig. 6) [55, 71]. Here, HAVCR2 is linked to neoplasm.